About Spotlight Therapeutics
Spotlight Therapeutics is a company based in Hayward (United States) founded in 2017.. Spotlight Therapeutics has raised $80.67 million across 5 funding rounds from investors including HHS, EPIQ and GordonMD Global Investments. The company has 32 employees as of December 31, 2022. Spotlight Therapeutics operates in a competitive market with competitors including Senti Biosciences, Beam Therapeutics, eGenesis, Annexon and TScan Therapeutics, among others.
- Headquarter Hayward, United States
- Employees 32 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spotlight Therapeutics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$80.67 M (USD)
in 5 rounds
-
Latest Funding Round
$533.94 K (USD), Grant
Sep 21, 2023
-
Investors
HHS
& 5 more
-
Employee Count
32
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Spotlight Therapeutics
Spotlight Therapeutics has successfully raised a total of $80.67M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $533.94 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $533,939
-
First Round
First Round
(02 Jan 2018)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Spotlight Therapeutics | Valuation |
investors |
|
| Mar, 2022 | Amount | Series B - Spotlight Therapeutics | Valuation | GordonMD Global Investments , EPIQ | |
| Nov, 2020 | Amount | Series A - Spotlight Therapeutics | Valuation | Google Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spotlight Therapeutics
Spotlight Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, EPIQ and GordonMD Global Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are provided in the biopharmaceutical sector.
|
Founded Year | Domain | Location | |
|
Diversified asset management services are offered by EPIQ.
|
Founded Year | Domain | Location | |
|
Magnetic Ventures is focused on transforming healthcare through AI and biotech investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spotlight Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spotlight Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spotlight Therapeutics Comparisons
Competitors of Spotlight Therapeutics
Spotlight Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Beam Therapeutics, eGenesis, Annexon and TScan Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
CAR-T and TIL immunotherapies for solid tumors are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spotlight Therapeutics
Frequently Asked Questions about Spotlight Therapeutics
When was Spotlight Therapeutics founded?
Spotlight Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Spotlight Therapeutics located?
Spotlight Therapeutics is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Is Spotlight Therapeutics a funded company?
Spotlight Therapeutics is a funded company, having raised a total of $80.67M across 5 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Jan 02, 2018.
How many employees does Spotlight Therapeutics have?
As of Dec 31, 2022, the latest employee count at Spotlight Therapeutics is 32.
What does Spotlight Therapeutics do?
Founded in 2017 and based in Hayward, United States, the company focuses on biotechnology in the oncology sector. Cancer therapeutics are developed through a proprietary platform called TAGE, by which CRISPR nuclease effectors are delivered to selected cells in vivo. A pipeline is maintained for applications in immuno-oncology, hematology, and ophthalmology, with operations centered on advancing gene editing technologies for therapeutic use.
Who are the top competitors of Spotlight Therapeutics?
Spotlight Therapeutics's top competitors include Hummingbird Bioscience, Lyell Immunopharma and eGenesis.
Who are Spotlight Therapeutics's investors?
Spotlight Therapeutics has 6 investors. Key investors include HHS, EPIQ, GordonMD Global Investments, Magnetic Ventures, and Google Ventures.